Myovant & Pfizer’s MyFembree receives nod from the FDA for endometriosis
GlobalData expects MyFembree, a combination therapy developed by Myovant and Pfizer, to be successful in the endometriosis space.
By
GlobalData
Latest in
GlobalData
Novel checkpoint inhibitors hit by another setback, but opportunities remain
A trial of novel checkpoint inhibitor monalizumab has been terminated after the drug failed to meet the efficacy threshold.
By
Top tweets: Reductions in dietary fat alter brain reward circuitry – and more
Clinical Trials Arena lists five of the top tweets on metabolic disorders in Q2 2022 based on data from GlobalData’s…
Findings suggest urban-rural divide in early-onset dementia diagnosis
The geographic disparities behind early-onset dementia highlight the need to bridge the urban-rural divide.
By
Monkeypox outbreak poses increased risk for 417,000 men who have sex with men
Concern over the monkeypox virus is higher among men who have sex with men (MSM) due to the nature of…
By
Industrial automation hiring in clinical trial operations rose to a year-high in July 2022
The latest figure is higher than the 49.7% of companies who were hiring for industrial automation related jobs a year…
By
The NHS acts to tackle the gender health gap in the UK
A strategy proposed by the DHSC sets bold ambitions to tackle deep-rooted, systemic issues within the UK’s healthcare system.
By
Filings buzz in pharma: 30% decrease in AI mentions in Q2 of 2022
The frequency of sentences related to AI between July 2021 and June 2022 was 421% higher than in 2016.
By